Viewing

RNA Club

The RNA Club, previously known as the transcription club, was formed in January 2014 to discuss well established topics of transcriptional regulation. With the acceptance of MOE Tier 3 grant and the formation of RNA Biology Centre in June 2015, the transcription club was renamed as RNA Club with a focus on RNA Biology and

Phase Ib/II Randomized, Open-Label Study of Doxorubicin and Cyclophosphamide with or without Low-Dose, Short-Course Sunitinib in the Pre-Operative Treatment of Breast Cancer. (Oncotarget, Aug 2016)

Wong AL1,2,3, Sundar R1,2, Wang TT3, Ng TC4, Zhang B4, Tan SH1,2, Soh TI1,2, Pang AS1,2, Tan CS1,2, Ow SG1,2, Wang L3,5, Mogro J2, Ho J1,2, Jeyasekharan AD1,2,3, Huang Y1,2, Thng CH6, Chan CW7, Hartman M7, Iau P7, Buhari SA7, Goh BC1,2,3,5, Lee SC1,2,3 1Department of Haematology-Oncology, National University Cancer Institute, National University Health System,

Success at NCAM 2016

Leong Wei Zhong, a PhD student from Dr Takaomi Sanda’s lab, was selected to present his scientific research findings at the 3rd NCIS Annual Research Meeting (NCAM 2016), which is jointly organised by Cancer Science Institute of Singapore (CSI Singapore) and National University Cancer Institute, Singapore (NCIS). He felt a sense of satisfaction as he

TIP60 Inhibits Metastasis by Ablating DNMT1-SNAIL2-driven Epithelial-Mesenchymal Transition Program (J Mol Cell Bio, Sep 2016)

Zhang Y1, Subbaiah VK1, Rajagopalan D2, Tham CY2, Abdullah LN1, Toh TB1, Gong M3, Tan TZ1, Jadhav SP1, Pandey AK1, Karnani N4, Chow EK5, Thiery JP6, Jha S7 1Cancer Science Institute of Singapore, National University of Singapore, Singapore. 2Cancer Science Institute of Singapore, National University of Singapore, Singapore Department of Biochemistry, Yong Loo Lin School

Leukemia & Lymphoma Cancers Awareness Month

How Can You Play Your Part? YOU CAN make a difference! Support our research by making a donation to CSI Singapore today. Your gift to us will accelerate our abilities to continue this vital work. Big or small, contributions will be carefully invested in important areas such as clinical trials, research technologies, and graduate program to

PRIMA-1 Targets the Vulnerability of Multiple Myeloma of Deregulated Protein Homeostasis through the Perturbation of ER Stress via p73 Demethylation (Oncotarget, Aug 2016)

Teoh PJ1,2, Bi C1, Sintosebastian C3, Tay LS4, Fonseca R3, Chng WJ1,3,2 1Cancer Science Institute Singapore, National University of Singapore, Singapore. 2Department of Haematology-Oncology, National University Cancer Institute, Singapore. 3Department of Hematology-Oncology, Mayo Clinic, Scottsdale, Arizona, USA. 4Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Abstract: Despite therapeutic advancement,